If you or someone you know has lost Lilly medicine due to recent hurricanes, please visit our website or call 1-800-Lilly-Rx (1-800-545-5979). https://e.lilly/3Y4Wo2T
关于我们
We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine,?contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.
- 网站
-
https://www.lilly.com/
礼来的外部链接
- 所属行业
- 制药业
- 规模
- 超过 10,001 人
- 总部
- Indianapolis，Indiana
- 类型
- 上市公司
- 领域
- Pharmaceutical Development、Pharmaceuticals、Biotech和Biopharmaceuticals
地点
-
主要
获取路线
Lilly Corporate Center
US，Indiana，Indianapolis，46285
礼来员工
动态
-
For people living with chronic conditions, access to effective medicines can make a real impact. That’s why we’re breaking down barriers to make our medicines accessible to more people. From the Lilly Insulin Value Program to innovative affordability solutions for treatments for obesity, psoriasis and psoriatic arthritis, we’re working to make our medicines more affordable for those who need them. https://e.lilly/3CAAm0Q #WeAreLilly
-
-
Roughly 63 million people in the U.S. have high levels of Lp(a), a common genetic risk factor for heart disease. Our scientists understand the impact of cardiometabolic diseases and are focused on developing game-changing solutions for the people living with them. Now, new Phase 2 data shared by our team at the American Heart Association Scientific Sessions 2024 evaluates a potential treatment option for adults with high risk for cardiovascular events. Learn more about the results shared and also published in JAMA here: https://e.lilly/3Z9sPyS
-
In the U.S. alone, almost 60% of people impacted by heart failure with preserved ejection fraction (HFpEF) also live with obesity. Today we announced detailed results from a Phase 3 study evaluating a potential treatment option for adults with HFpEF and obesity. Learn more about these results published in The New England Journal of Medicine and presented at American Heart Association Scientific Sessions 2024: https://e.lilly/3CvxMJv
-
No child should die of diabetes. That’s the vision of Life for a Child an organization that provides support to children and youth with diabetes in resource-limited settings. Over the last 15 years, we’ve provided more than 8.1 million vials and cartridges of medicine to support the Life for a Child program. Last year, that helped more than 50,000 children and youth – a number we hope to help triple by 2030. One person impacted by this program is Betty, who lives with type 1 diabetes in Ethiopia. Because of their resources, she’s able to look to the future. (She wants to be a doctor!) Click to read Life for a Child’s profile of Betty. #WorldDiabetesDay #WeAreLilly
-
Creating ways for people to live healthier isn't work that can be done alone. We know our focus on making medicines that people around the world depend on comes with a deep responsibility to be the kind of company that people want to work for and with. That's why we're honored to be included in the top 10 of the Forbes list of America's Best Companies. Thank you to everyone—within our organization and beyond—who helped us achieve such an esteemed recognition. See the full list here: https://e.lilly/3O7Ack0 #WeAreLilly
Forbes America's Best Companies To Work For & Invest In 2025 List
social-www.forbes.com
-
Addressing complex, chronic diseases to improve people’s lives includes exploring options to reduce the risk of complications before they develop. Today we shared results from a Phase 3 study that evaluated a potential treatment for adults with obesity or overweight and pre-diabetes, aimed at achieving long-term weight management and reducing the risk of progression to type 2 diabetes. Learn more about these clinical trial results published in NEJM Group and recently presented at #ObesityWeek2024: https://e.lilly/3AGg7y4
-
We’re working around the clock to make medicines for the people who need them. One of the places that’s happening? North Carolina. We talked to three of our employees (one’s also a patient!) about the hard work they’re seeing on the ground floors of their facilities, day in and day out. Thanks to people like Becca, Stephen and Kent for putting our purpose into action. https://e.lilly/3O9cljY
-
Music isn’t just a love for Myra Garcia—it sustains her. Now living with early Alzheimer’s disease, a passion for song keeps her heart full and her life active. See more in the “The Power of Music.” https://e.lilly/42ClzeW #WeAreLilly